IGF2BP2 and diabetic kidney disease: In the specific context of diabetic kidney disease (DKD), IMP2 has been identified as a pivotal regulator that stabilizes SP1 mRNA, promoting macrophage infiltration and polarization toward the pro-inflammatory M1-like phenotype, which exacerbates renal inflammation and fibrosis [121].